634 related articles for article (PubMed ID: 32132672)
1. Targeting immunometabolism as an anti-inflammatory strategy.
Pålsson-McDermott EM; O'Neill LAJ
Cell Res; 2020 Apr; 30(4):300-314. PubMed ID: 32132672
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
Kornberg MD; Bhargava P; Kim PM; Putluri V; Snowman AM; Putluri N; Calabresi PA; Snyder SH
Science; 2018 Apr; 360(6387):449-453. PubMed ID: 29599194
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Modulation in Macrophage Effector Function.
Diskin C; Pålsson-McDermott EM
Front Immunol; 2018; 9():270. PubMed ID: 29520272
[TBL] [Abstract][Full Text] [Related]
4. Targeting immunometabolism against acute lung injury.
Ning L; Shishi Z; Bo W; Huiqing L
Clin Immunol; 2023 Apr; 249():109289. PubMed ID: 36918041
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation by dimethyl fumarate treatment improves mouse sciatic nerve regeneration.
Bombeiro AL; Pereira BTN; Bonfanti AP; Oliveira ALR
Brain Res Bull; 2020 Jul; 160():24-32. PubMed ID: 32305403
[TBL] [Abstract][Full Text] [Related]
6. Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis.
Yadav SK; Soin D; Ito K; Dhib-Jalbut S
J Mol Med (Berl); 2019 Apr; 97(4):463-472. PubMed ID: 30820593
[TBL] [Abstract][Full Text] [Related]
7. Glycolysis in Innate Immune Cells Contributes to Autoimmunity.
Xu Y; Chen Y; Zhang X; Ma J; Liu Y; Cui L; Wang F
Front Immunol; 2022; 13():920029. PubMed ID: 35844594
[TBL] [Abstract][Full Text] [Related]
8. Therapies Targeting Trained Immune Cells in Inflammatory and Autoimmune Diseases.
Municio C; Criado G
Front Immunol; 2020; 11():631743. PubMed ID: 33569065
[TBL] [Abstract][Full Text] [Related]
9. Macrophage metabolic profile is altered by hydroxyapatite particle size.
Shanley LC; Mahon OR; O'Rourke SA; Neto NGB; Monaghan MG; Kelly DJ; Dunne A
Acta Biomater; 2023 Apr; 160():311-321. PubMed ID: 36754270
[TBL] [Abstract][Full Text] [Related]
10. Rapalogs and mTOR inhibitors as anti-aging therapeutics.
Lamming DW; Ye L; Sabatini DM; Baur JA
J Clin Invest; 2013 Mar; 123(3):980-9. PubMed ID: 23454761
[TBL] [Abstract][Full Text] [Related]
11. Metabolic regulation of type I interferon production.
O'Carroll SM; Henkel FDR; O'Neill LAJ
Immunol Rev; 2024 May; 323(1):276-287. PubMed ID: 38465724
[TBL] [Abstract][Full Text] [Related]
12. Targeting Evolutionary Conserved Oxidative Stress and Immunometabolic Pathways for the Treatment of Respiratory Infectious Diseases.
Erlich JR; To EE; Liong S; Brooks R; Vlahos R; O'Leary JJ; Brooks DA; Selemidis S
Antioxid Redox Signal; 2020 May; 32(13):993-1013. PubMed ID: 32008371
[No Abstract] [Full Text] [Related]
13. A comparison study between dimethyl itaconate and dimethyl fumarate in electrophilicity, Nrf2 activation, and anti-inflammation
Zhang Y; Zhou YJ; Tang JS; Lan JQ; Kang YY; Wu L; Peng Y
J Asian Nat Prod Res; 2022 Jun; 24(6):577-588. PubMed ID: 34292106
[TBL] [Abstract][Full Text] [Related]
14. Dimethyl fumarate preserves left ventricular infarct integrity following myocardial infarction via modulation of cardiac macrophage and fibroblast oxidative metabolism.
Mouton AJ; Flynn ER; Moak SP; Aitken NM; Omoto ACM; Li X; da Silva AA; Wang Z; do Carmo JM; Hall JE
J Mol Cell Cardiol; 2021 Sep; 158():38-48. PubMed ID: 34023353
[TBL] [Abstract][Full Text] [Related]
15. Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.
Cunill V; Massot M; Clemente A; Calles C; Andreu V; Núñez V; López-Gómez A; Díaz RM; Jiménez MLR; Pons J; Vives-Bauzà C; Ferrer JM
Front Immunol; 2018; 9():1097. PubMed ID: 29896193
[TBL] [Abstract][Full Text] [Related]
16. Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis.
Diebold M; Sievers C; Bantug G; Sanderson N; Kappos L; Kuhle J; Lindberg RLP; Derfuss T
J Autoimmun; 2018 Jan; 86():39-50. PubMed ID: 28958667
[TBL] [Abstract][Full Text] [Related]
17. Dimethyl fumarate treatment alters NK cell function in multiple sclerosis.
Smith MD; Calabresi PA; Bhargava P
Eur J Immunol; 2018 Feb; 48(2):380-383. PubMed ID: 29108094
[TBL] [Abstract][Full Text] [Related]
18. [Clinical guidelines for the use of dimethyl fumarate in relapsing-remitting multiple sclerosis].
Alifirova VM; Boiko AN; Vlasov YV; Davydovskaya MV; Zakharova MN; Malkova NA; Popova EV; Sivertseva SA; Spirin NN; Khachanova NV; Shmidt ТЕ
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(1):97-102. PubMed ID: 28252608
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Baló Concentric Sclerosis Response to Dimethyl Fumarate.
French S; Crowder D
Pediatr Neurol; 2019 Aug; 97():71-73. PubMed ID: 31047755
[No Abstract] [Full Text] [Related]
20. Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells.
Laselva O; Allegretta C; Di Gioia S; Avolio C; Conese M
Cells; 2021 Aug; 10(8):. PubMed ID: 34440900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
